About ARTES Biotechnology
ARTES Biotechnology GmbH is a service provider for production and optimisation of microbial recombinant protein strains, especially with the yeast organisms Hansenula and Arxula. The independent company, founded in 2002, holds worldwide patents and licences for these and further technology platforms. ARTES` team is engaged in the production of recombinant proteins for clients in White Biotechnology (food and/ feed industry as well as/ fine chemical enzyme manufacturers industry) and in Red Biotechnology (pharmaceutical industry).
- Founding: 2002
- Focus : Service
- Employees: 11-50
- Industry : Biotechnology
News about ARTES Biotechnology
06-Sep-2011 | research and development
ARTES Biotechnology GmbH and NL Biotechnologies LLC join in a strategic collaboration and co-marketing alliance
ARTES Biotechnology and NL Biotechnologies started a strategic collaboration. With signing this collaboration agreement the two companies combine their ...
29-Sep-2010 | business & finance
ARTES Steps Further Into the Vaccine Business by Acquiring Anavax
ARTES Biotechnology announced the acquirement of the ANAVAX virus-like particle (VLP) technology from Select Vaccines Ltd. ANAVAX is a patent-protected VLP ...
04-May-2010 | business & finance
Q Chip and ARTES Biotechnology announce collaboration to develop sustained release formulations of therapeutic proteins
Q Chip Ltd and ARTES Biotechnology GmbH announced that they have signed a Collaborative Agreement to explore the development of a new sustained release ...
17-Nov-2009 | business & finance
ARTES and Rhein Minapharm continue their successful product development collaboration
ARTES Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE, jointly announced the successful production of a new target of a ...
15-Jan-2008 | business & finance
ARTES and Minapharm sign long-term strategic development agreement
ARTES Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE jointly announced the start of a strategic collaboration to develop ...
20-Jun-2006 | business & finance
ARTES Biotechnology GmbH and ProteoNic BV start research collaboration
ARTES Biotechnology GmbH, Germany, and ProteoNic B.V., The Netherlands, announced the start of their research collaboration. Both companies will join ...